A Long Term Safety Study of Degarelix in Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix

Trial Locations (62)

Unknown

Institut Jules Bordet, Brussels

St. Elisabethziekenhuis, Turnhout

Hopital Jean Minjoz, Besançon

Institut Bergonié, Bordeaux

Centre Francois Baclesse, Caen

CHU Henri Mondor, Créteil

Centre Oscar Lambret, Lille

Centre Leon Berard, Lyon

Hopital de la Timone, Marseille

CRLC Val d' Aurelle - Oncology Radiotherapy, Montpellier

Hôpital Saint Louis - Radiotherapy Departement, Paris

Hôpital Tenon, Paris

Clinique Francheville, Périgueux

CHU La Milétrie - Oncology Radiotherapy, Poitiers

Clinique Saint Brieuc, Saint-Brieuc

Centre de Lutte Contre le Cancer Nantes-Atlantique Centre René Gauducheau, Saint-Herblain

Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez

Centre Paul Strauss, Strasbourg

Centre de radiologie Saint Louis, Toulon

Clinique du Parc, Toulouse

IGR, Villejuif

Azienda Ospedaliero Universitaria Ospedali riuniti, Ancona

Policlinico S.Orsola Malpighi - Universita' degli Studi di Bologna, Bologna

Clinica Urologica 1 Universita Firenze, Florence

Fondazione IRCCS Istituto Nazionale Tumori, Milan

Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan

Azienda Ospedaliera Universitaria Federico II, Napoli

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone dell'Universita' degli Studi di Palermo, Palermo

Clinica Urologica - Azienda Ospedaliera di Perugia, Perugia

Azienda Ospedaliera S. Andrea - Universita' la Sapienza di Roma, Roma

S.C. Di Urologia - IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo

Azienda Ospedaliero Universitaria S. Giovanni Battista - Molinette, Torino

Hospital Fernando da Fonseca, Amadora

Hospitais Universidade Coimbra, Coimbra

Centro Hospitalar Lisboa Norte, Hospital Santa Maria, Lisbon

Hospital S.João, Porto

Hospital Universitario Principe de Asturias, Alcalá de Henares-Madrid

Fundacion Hospital Alcorcón, Alcorcón

Fundación Puigvert, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Universitari Vall d´Hebron, Barcelona

Hospital de Basurto, Bilbao

Hospital Clinico Universitario S. Carlos, Madrid

Hospital Doce de Octubre, Madrid

Hospital universitario Ramón y Cajal, Madrid

Hospital Universitario Puerta de Hierro, Majadahonda

Hospital Manacor, Manacor

Hospital Universitario Central de Asturias, Oviedo

Hospital Santiago de Compostela, Santiago de Compostela

Hospital Virgen Macarena, Seville

Fundación IVO, Valencia

Hospital Xeral de Vigo, Vigo

Investigational site, Gothenburg

SU/Sahlgrenska, Gothenburg

Helsingborgs Lasarett, Helsingborg

Universitetssjukhuset MAS, Malmo

Södertälje Sjukhus, Södertälje

Uppsala/Akademiska sjukhuset, Uppsala

Ankara University Faculty of Medicine - Sıhhıye, Ankara

Cerrahpasa Faculty of Medicine - Kocamustafapasa, Istanbul

Istanbul University Faculty of Medicine - ÇAPA, Istanbul

Marmara University Faculty of Medicine - Altunizade, Istanbul

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT00967018 - A Long Term Safety Study of Degarelix in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter